Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives medroxyprogesterone, or placebo over 12 months
Article Abstract:
Women who experience no menstrual cycles due to understimulation of the thalamus may experience increases in bone mineral density with oral contraceptive treatment. Researchers treated 24 women aged 14 to 28 years and who experienced either no menstrual cycles or scanty menstrual cycles with either oral contraceptives, medroxyprogesterone, or placebo for 12 months. Only women with no menstrual cycles due to understimulation of the thalamus who were treated with oral contraceptives experienced increases in bone mineral measurements in the spine and in total body bone. Bone mineral was measured using dual-energy x-ray absorptiometry.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
The epidemiology of oral contraceptive use: a critical review of the studies on oral contraceptives and the health of young women
Article Abstract:
Newer combined oral contraceptives do not seem to pose a significantly higher risk of venous thromboembolism, according to an epidemiological analysis of recent studies. Possible confounding factors and biases have been identified that could affect estimates of the risk of venous thromboembolism in comparisons of third- and second-generation oral contraceptives.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Oral contraceptive use in perimenopause
Article Abstract:
Women can still ovulate and become pregnant during perimenopause, so they should still use some type of contraceptive. Oral contraceptives not only prevent pregnancy but also have other health benefits. Perimenopause is the medical term for the five-year period before menstruation actually stops completely.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Binding of oral contraceptive progestogens to serum proteins and cytoplasmic receptor. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation
- Abstracts: Second trimester abortion using isosorbide mononitrate in addition to gemeprost compared with gemeprost alone: A double-blind randomized, placebo-controlled multicenter trial
- Abstracts: Cost-effectiveness of monoclonal antibodies to gram-negative endotoxin in the treatment of gram-negative sepsis in ICU patients
- Abstracts: Rates of homicide, suicide, and firearm-related death among children - 26 industrialized countries. Temporal Variations in School-Associated Student Homicide and Suicide Events--United States, 1992-1999
- Abstracts: First-trimester diagnosis of fetal congenital heart disease by transvaginal two-dimensional and Doppler echocardiography